Article
Antibody-directed neutralization of annexin II (ANX II) inhibits neoangiogenesis and human breast tumor growth in a xenograft model.
Experimental and molecular pathology - 1 Feb 2012
Sharma Meena, Blackman Marc R, Sharma Mahesh C
Abstract excerpt
Activation of the fibrinolytic pathway has long been associated with human breast cancer. Plasmin is the major end product of the fibrinolytic pathway and is critical for normal physiological functions. The mechanism by which plasmin is generated in breast cancer is not yet fully described. We previously identified annexin II (ANX II), a fibrinolytic receptor, in human breast tumor tissue samples and observed a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
